UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Journal of clinical oncology, 2015-09, Vol.33 (27), p.2999-3007

2015

Volltextzugriff (PDF)

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Cancer, 2018-08, Vol.124 (16), p.3381-3389

2018

Volltextzugriff (PDF)

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1558-1568

2020

Volltextzugriff (PDF)

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Journal of clinical oncology, 2018-01, Vol.36 (3), p.254-261

2018

Volltextzugriff (PDF)

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2769-2777

2019

Volltextzugriff (PDF)

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

American journal of roentgenology (1976), 2020-05, Vol.214 (5), p.987

2020

Volltextzugriff (PDF)

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Pediatric blood & cancer, 2013-06, Vol.60 (6), p.994-1000

2013

Volltextzugriff (PDF)

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer, 2020-12, Vol.126 (23), p.5156-5164

2020

Volltextzugriff (PDF)

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Pediatric blood & cancer, 2016-07, Vol.63 (7), p.1307-1309

2016

Volltextzugriff (PDF)

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.641-646

2013

Volltextzugriff (PDF)

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4573-4579

2012

Volltextzugriff (PDF)

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3047-3056

2022

Volltextzugriff (PDF)

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3189-3194

2016

Volltextzugriff (PDF)

Parental views on tissue banking in pediatric oncology patients

Pediatric blood & cancer, 2011-12, Vol.57 (7), p.1217-1221

2011

Volltextzugriff (PDF)

Essential medicines for childhood cancer in Europe

The lancet oncology, 2023-02, Vol.24 (2), p.e67-e67

2023

Volltextzugriff (PDF)

Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer

JAMA pediatrics, 2019-05, Vol.173 (5), p.477

2019

Volltextzugriff (PDF)

An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer

JNCI : Journal of the National Cancer Institute, 2016-06, Vol.108 (6), p.djv392-djv392

2016

Volltextzugriff (PDF)

Novel therapy for pediatric and adolescent kidney cancer

Cancer and metastasis reviews, 2019-12, Vol.38 (4), p.643-655

2019

Volltextzugriff (PDF)

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1564-1570

2018

Volltextzugriff (PDF)

Chemotherapy drug shortages in pediatric oncology: a consensus statement

Pediatrics (Evanston), 2014-03, Vol.133 (3), p.e716

2014

Volltextzugriff (PDF)

Incidence of childhood cancer in Canada during the COVID-19 pandemic

Canadian Medical Association journal (CMAJ), 2021-11, Vol.193 (47), p.E1798

2021

Volltextzugriff (PDF)

When “a headache is not just a headache”: A qualitative examination of parent and child experiences of pain after childhood cancer

Psycho-oncology (Chichester, England), 2019-09, Vol.28 (9), p.1901-1909

2019

Volltextzugriff (PDF)

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Cancer, 2020-06, Vol.126 (12), p.2866-2871

2020

Volltextzugriff (PDF)

Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high‐risk neuroblastoma in a large Canadian cohort

Pediatric blood & cancer, 2023-06, Vol.70 (6), p.e30286-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

PublikationsformArtikel

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(66)

Sprache

Englisch
(76)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

Children's Oncology Group's 2013 blueprint for research: Renal tumors

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Parental views on tissue banking in pediatric oncology patients

Essential medicines for childhood cancer in Europe

Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer

An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer

Novel therapy for pediatric and adolescent kidney cancer

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study

Chemotherapy drug shortages in pediatric oncology: a consensus statement

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group

Incidence of childhood cancer in Canada during the COVID-19 pandemic

When “a headache is not just a headache”: A qualitative examination of parent and child experiences of pain after childhood cancer

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high‐risk neuroblastoma in a large Canadian cohort

Aktive Filter

Suchergebnisse filtern